Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial – The Lancet Respiratory Medicine
The post Small RCT: Peginterferon lambda increases viral clearance in outpatients with COVID-19 appeared first on Links Medicus.